Colchicine use in isolated renal AA amyloidosis

Meneses, Carlos F; Egües, César A; Uriarte, Miren; Belzunegui, Joaquín; Rezola, Marta.
Reumatol. clín. (Barc.) ; 11(4): 242-243, jul.-ago. 2015. iluls
Artículo en Inglés | IBECS (España) | ID: ibc-136965

Documentos relacionados

  1. AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine.
  2. A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis.
  3. Renal involvement in monogenic autoinflammatory diseases: A narrative review.
  4. A soluble allergen sensor sounds the alarm.
  5. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
  6. Resistance to chicken amyloid arthropathy is associated with a dysfunctional mutation in serum amyloid A.
  7. Serum amyloid A and risks of all-cause and cardiovascular mortality in chronic kidney disease: a systematic review and dose-response meta-analysis.
  8. [The analysis of secondary AA-amyloidosis current etiology and its influence on the approaches for diagnosis and treatment].
  9. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.
  10. [Association study of serum LncRNA MALAT1 and SAA with type 2 diabetic kidney disease].